Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.

Barry Mirtsching, Veena Charu, Saroj Vadhan-Raj, Alan B. Colowick, Gregory Rossi, Dianne Tomita, William P. McGuire

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined analysis.'. Together they form a unique fingerprint.

Medicine & Life Sciences